Chinese investors of Citic acquired stake at Singapore medical firm for $817 million
Citic Private Equity, a Chinese private equity firm, has acquired stake at Biosensors International Group, a Singapore-based medical device maker, for $817 million.
Citic Private Equity Funds Management already controls about 19.6 percent of Biosensors. Biosensors International Group is a medical device company that specializes in developing, manufacturing and licensing technologies for use in interventional cardiology procedures and critical care. The company was listed in the Mainboard of the Singapore Exchange (SGX) in May 2005. (CITIC Capital Partners, the private equity arm of CITIC Capital, invests globally, operates in China, Japan and the US and manages $2.6 billion of committed capital.)
Citic Private Equity is listed in the Chinese Private Equity and Venture Capital Directory with the code OR48
More details follows from Bloomberg
Investors Directory 2022
